SCHOTT Pharma AG & Co. KGaA Share Price
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.95 EUR | -0.19% | -2.63% | +10.00% |
08:54am | SCHOTT PHARMA : Gets a Neutral rating from Barclays | ZD |
22/04 | SCHOTT PHARMA : Jefferies remains Neutral | ZD |
Sales 2024 * | 981M 1.06B 88.18B | Sales 2025 * | 1.15B 1.24B 103B | Capitalization | 5.58B 6B 501B |
---|---|---|---|---|---|
Net income 2024 * | 151M 163M 13.57B | Net income 2025 * | 189M 203M 16.99B | EV / Sales 2024 * | 5.89 x |
Net Debt 2024 * | 201M 216M 18.04B | Net Debt 2025 * | 184M 199M 16.58B | EV / Sales 2025 * | 5.01 x |
P/E ratio 2024 * |
37
x | P/E ratio 2025 * |
29.6
x | Employees | 4,687 |
Yield 2024 * |
0.43% | Yield 2025 * |
0.54% | Free-Float | 23% |
1 day | -0.19% | ||
1 week | -2.63% | ||
Current month | -6.00% | ||
1 month | -7.32% | ||
3 months | -5.71% | ||
6 months | +30.69% | ||
Current year | +10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 01/22/01 |
Director of Finance/CFO | 43 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 01/23/01 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 01/23/01 |
Chairman | 59 | - |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 36.96 | -0.16% | 31 351 |
09/24/09 | 37.02 | -4.34% | 65,965 |
08/24/08 | 38.7 | +2.76% | 38,666 |
07/24/07 | 37.66 | +1.40% | 48,360 |
06/24/06 | 37.14 | -2.16% | 27,319 |
Delayed Quote Xetra, May 10, 2024 at 08:29 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.00% | 6.01B | |
-4.57% | 182B | |
+0.24% | 110B | |
-3.90% | 67.92B | |
+3.16% | 50.96B | |
+9.66% | 44.7B | |
+2.70% | 40.66B | |
+21.56% | 27.6B | |
+4.31% | 26.63B | |
-0.12% | 24.98B |
- Stock Market
- Equities
- 1SXP Stock